138
Publications
9.7K
Citations
57
H-Index
1994
Active since
Philip Wenzel is an author at Johannes Gutenberg University Mainz specializing in medicine, physiology, and pharmacology.
Top concepts
MedicineCardiovascular DiseasePhysiologyVascular BiologyBiochemistryPharmacologyOxidative StressNatural SciencesAtherosclerosisInflammation
Publications per year
1994–2024
138
138
The SGLT2 inhibitor empagliflozin improves the primary diabetic complications in ZDF rats
Sebastian Steven, Matthias Oelze, Alina Hanf et al. · Redox Biology · 2017 · 295 citations · Full text
Rows per page
1–5 of 138